Cargando…

Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease

BACKGROUND: MicroRNAs (miRNAs) have been associated with the Hirschsprung disease (HSCR) pathogenesis, however, the findings are still inconclusive. We aimed to investigate the effect of miRNA-206 and its targets, fibronectin 1 (FN1), serum deprivation response (SDPR), and paired box 3 (PAX3) expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunadi, Budi, Nova Yuli Prasetyo, Kalim, Alvin Santoso, Santiko, Wiwid, Musthofa, Fuad Dheni, Iskandar, Kristy, Makhmudi, Akhmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323865/
https://www.ncbi.nlm.nih.gov/pubmed/30616633
http://dx.doi.org/10.1186/s13023-018-0973-5
_version_ 1783385857035599872
author Gunadi
Budi, Nova Yuli Prasetyo
Kalim, Alvin Santoso
Santiko, Wiwid
Musthofa, Fuad Dheni
Iskandar, Kristy
Makhmudi, Akhmad
author_facet Gunadi
Budi, Nova Yuli Prasetyo
Kalim, Alvin Santoso
Santiko, Wiwid
Musthofa, Fuad Dheni
Iskandar, Kristy
Makhmudi, Akhmad
author_sort Gunadi
collection PubMed
description BACKGROUND: MicroRNAs (miRNAs) have been associated with the Hirschsprung disease (HSCR) pathogenesis, however, the findings are still inconclusive. We aimed to investigate the effect of miRNA-206 and its targets, fibronectin 1 (FN1), serum deprivation response (SDPR), and paired box 3 (PAX3) expressions on multifactorial HSCR in Indonesia, a genetically distinct group within Asia. METHODS: We determined the miRNA-206, FN1, SDPR and PAX3 expressions in both the ganglionic and aganglionic colon of HSCR patients and control colon by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: Twenty-one sporadic HSCR patients and thirteen controls were ascertained in this study. The miRNA-206 expression was up-regulated (2-fold) in the ganglionic colon and down-regulated (0.5-fold) in the aganglionic colon compared to the control group (ΔC(T) 12.4 ± 3.0 vs. 14.1 ± 3.9 vs. 13.1 ± 2.7), but these differences did not reach significant levels (p = 0.48 and p = 0.46, respectively). Interestingly, the FN1 expression was significantly increased in both the ganglionic (38-fold) and aganglionic colon (18-fold) groups compared to the control group ΔC(T) 5.7 ± 3.0 vs. 6.8 ± 2.3 vs. 11.0 ± 5.0; p = 0.001 and p = 0.038, respectively). Furthermore, the expressions of SDPR were similar in the ganglionic, aganglionic and control colon groups (ΔC(T) 2.4 ± 0.6 vs. 2.2 ± 0.4 vs. 2.1 ± 0.6; p = 0.16 and p = 0.39, respectively), while no change was observed in the PAX3 expression between the ganglionic, aganglionic, and control colon groups (ΔC(T) 3.8 ± 0.8 vs. 4.1 ± 0.8 vs. 3.7 ± 1.1; p = 0.83 and p = 0.44, respectively). CONCLUSION: Our study is the first report of aberrant FN1 expressions in the colon of patients with HSCR and supplies further insights into the contribution of aberrant FN1 expression in the HSCR pathogenesis.
format Online
Article
Text
id pubmed-6323865
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63238652019-01-11 Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease Gunadi Budi, Nova Yuli Prasetyo Kalim, Alvin Santoso Santiko, Wiwid Musthofa, Fuad Dheni Iskandar, Kristy Makhmudi, Akhmad Orphanet J Rare Dis Research BACKGROUND: MicroRNAs (miRNAs) have been associated with the Hirschsprung disease (HSCR) pathogenesis, however, the findings are still inconclusive. We aimed to investigate the effect of miRNA-206 and its targets, fibronectin 1 (FN1), serum deprivation response (SDPR), and paired box 3 (PAX3) expressions on multifactorial HSCR in Indonesia, a genetically distinct group within Asia. METHODS: We determined the miRNA-206, FN1, SDPR and PAX3 expressions in both the ganglionic and aganglionic colon of HSCR patients and control colon by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: Twenty-one sporadic HSCR patients and thirteen controls were ascertained in this study. The miRNA-206 expression was up-regulated (2-fold) in the ganglionic colon and down-regulated (0.5-fold) in the aganglionic colon compared to the control group (ΔC(T) 12.4 ± 3.0 vs. 14.1 ± 3.9 vs. 13.1 ± 2.7), but these differences did not reach significant levels (p = 0.48 and p = 0.46, respectively). Interestingly, the FN1 expression was significantly increased in both the ganglionic (38-fold) and aganglionic colon (18-fold) groups compared to the control group ΔC(T) 5.7 ± 3.0 vs. 6.8 ± 2.3 vs. 11.0 ± 5.0; p = 0.001 and p = 0.038, respectively). Furthermore, the expressions of SDPR were similar in the ganglionic, aganglionic and control colon groups (ΔC(T) 2.4 ± 0.6 vs. 2.2 ± 0.4 vs. 2.1 ± 0.6; p = 0.16 and p = 0.39, respectively), while no change was observed in the PAX3 expression between the ganglionic, aganglionic, and control colon groups (ΔC(T) 3.8 ± 0.8 vs. 4.1 ± 0.8 vs. 3.7 ± 1.1; p = 0.83 and p = 0.44, respectively). CONCLUSION: Our study is the first report of aberrant FN1 expressions in the colon of patients with HSCR and supplies further insights into the contribution of aberrant FN1 expression in the HSCR pathogenesis. BioMed Central 2019-01-07 /pmc/articles/PMC6323865/ /pubmed/30616633 http://dx.doi.org/10.1186/s13023-018-0973-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gunadi
Budi, Nova Yuli Prasetyo
Kalim, Alvin Santoso
Santiko, Wiwid
Musthofa, Fuad Dheni
Iskandar, Kristy
Makhmudi, Akhmad
Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease
title Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease
title_full Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease
title_fullStr Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease
title_full_unstemmed Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease
title_short Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease
title_sort aberrant expressions of mirna-206 target, fn1, in multifactorial hirschsprung disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323865/
https://www.ncbi.nlm.nih.gov/pubmed/30616633
http://dx.doi.org/10.1186/s13023-018-0973-5
work_keys_str_mv AT gunadi aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease
AT budinovayuliprasetyo aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease
AT kalimalvinsantoso aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease
AT santikowiwid aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease
AT musthofafuaddheni aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease
AT iskandarkristy aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease
AT makhmudiakhmad aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease